Tiffany, Kors to Re...
Health Care: Drugs
Pacira Pharmaceuticals Inc. (PCRX: NASDAQ)
$29.30 -0.43 | -1.45%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -52.28M | -43.33M | -27.15M | -31.71M |
| Operating Gains/Losses | 1.06M | 273.00K | 11.00K | 1.71M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -2.24M | -922.00K | 264.00K | 1.13M |
| (Increase) Decrease in Inventories | -10.83M | 360.00K | 124.00K | 299.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 14.00K | 48.00K | 210.00K |
| (Decrease) Increase In Payables | 1.39M | 2.55M | -612.00K | -4.44M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | -2.18M | 4.10M |
| (Increase) Decrease In Other Working Capital | -18.18M | 1.09M | 1.01M | 2.72M |
| Other Non-Cash Items | 4.78M | 3.70M | -652.00K | 709.00K |
| Net Cash From Continuing Operations | -70.13M | -31.00M | -24.88M | -20.84M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -70.13M | -31.00M | -24.88M | -20.84M |
| Sale of Property, Plant & Equipment | 1.00K | 14.00K | 1.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 53.12M | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -18.26M | -6.17M | -6.77M | -5.51M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -54.05M | -29.97M | 0.00 | 0.00 |
| Other Cash from Investing Activities | -10.34M | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -29.52M | -36.12M | -6.77M | -5.51M |
| Issuance of Debt | 27.50M | 0.00 | 7.50M | 21.25M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 63.72M | 87.16M | 2.00K | 3.00K |
| Repayment of Long-Term Debt | -26.25M | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | -2.00K | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.36M | 0.00 | 43.20M | -215.00K |
| Net Cash From Financing Activities | 63.61M | 87.16M | 50.70M | 21.04M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -36.04M | 20.04M | 19.06M | -5.31M |
Portfolios with PCRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- UserDayTrading Test 1
- Contributor10 Best-Performing IPOs of ...
- Contributor10 Health-Care Stocks Outpe...
Latest PCRX Headlines from TheStreet
- TheStreet Ratings Top 10 Rating Changes 05.13.13 | 01:05 pm
- SALT 2013: The 5 Best Ideas of the Year Ahead 05.10.13 | 04:05 pm
- Pacira Pharmaceuticals Inc. Stock Downgraded (PCRX) 05.10.13 | 05:05 am
- Top Insider Trades: AGCO ECHO PCRX TWER 03.26.13 | 04:03 pm
- Top Insider Trades: CHDN, PCRX, ULTA, PMBC 03.22.13 | 08:03 am
- 'Mad Money' Lightning Round: Stick With Cummins, Sell Micron 03.14.13 | 06:03 am
- Cramer's 'Mad Money' Recap: A Resting Bull Market 03.13.13 | 07:03 pm
- Pacira Pharmaceuticals Inc. Stock Upgraded (PCRX) 03.11.13 | 05:03 am
- 4 Stocks Rising on Unusual Volume 02.01.13 | 03:02 pm
- Top Insider Trades: BAC LGND PCRX BDBD 01.28.13 | 08:01 am
Press Releases for PCRX
- Analysis Of Postsurgical Pain Management Finds Opioid-Related Adverse Events Drive Longer Hospital Stays, Greater Cost And Higher Likelihood Of Readmission - Business Wire 03.27.13 | 06:03 am
- Pacira Pharmaceuticals, Inc. To Present At The Barclays Global Healthcare Conference - Business Wire 03.06.13 | 06:03 am
- Pacira Pharmaceuticals, Inc. Announces Timing For 2012 Financial Results Webcast And Conference Call - Business Wire 02.28.13 | 06:02 am
- Pacira Pharmaceuticals, Inc. To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 06:02 am
- Pacira Pharmaceuticals, Inc. Announces Pricing Of $110 Million Private Offering Of Convertible Senior Notes - Business Wire 01.17.13 | 08:01 am
- Pacira Pharmaceuticals, Inc. Announces Proposed Offering Of $100 Million Of Convertible Senior Notes - Business Wire 01.15.13 | 04:01 pm
- New Publication Suggests Higher Opioid Use In The Postsurgical Setting May Be Linked To Extended Hospital Stay And Increased Cost Of Care - Business Wire 12.18.12 | 06:12 am
- Http://www.aratanatherapeutics.com/ - Business Wire 12.06.12 | 06:12 am
- Pacira Pharmaceuticals, Inc. To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 06:11 am
- New Data Demonstrate Reduction In Opioid Use, Hospital Cost And Length Of Stay With EXPAREL As The Foundation Of A Multimodal Regimen - Business Wire 11.20.12 | 06:11 am
Partner Headlines for PCRX
- UPDATE: Wedbush Raises PT to $32 on Pacira Pharmaceuticals on Long-Term Outlook - Benzinga 03.07.13 | 01:03 pm
- 3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds - Seeking Alpha 04.13.12 | 07:04 pm
- Noteworthy Insider Buys In The Healthcare Sector Last Week - Seeking Alpha 11.29.11 | 08:11 am
- How Will Congress' Budget Cuts Affect Health Care? - Benzinga 11.21.11 | 01:11 pm
- Decision Due For Pacira's Flagship Drug EXPAREL - Seeking Alpha 10.31.11 | 08:10 am
- Biotech Catalysts for Third Quarter - Seeking Alpha 06.24.11 | 06:06 pm
- 6 Stocks With Recent CFO Buys - Seeking Alpha 02.25.11 | 08:02 am
- 7 Diverse U.S. IPOs Test Investor Appetites This Week - Seeking Alpha 02.13.11 | 06:02 am
- RPT-IPO VIEW-Biotech IPO spurt to test U.S. market - Reuters 02.06.11 | 10:02 am
- IPO VIEW-Biotech IPO spurt to test U.S. market - Reuters 02.04.11 | 07:02 pm
